Lillie D. Shockney RN, BS, MAS, HON-ONN-CGUniversity Distinguished Service Professor of Breast Cancer, Professor of Surgery, Johns Hopkins University School of Medicine; Co-Founder, Academy of Oncology Nurse & Patient Navigators; Co-Developer, Work Stride — Managing Cancer at Work, Johns Hopkins Healthcare Solutions, Baltimore, Maryland
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG is well known in the cancer field, especially in navigation, survivorship, patient centered care, preservation of quality of life, end of life planning and care, improving the cancer patient’s experience and clinical outcomes. She clinically specializes in breast cancer care. Her public speaking, literary work, and notable roles she has held over the last 40+ years are well known to many.
- University Distinguished Service Professor of Breast Cancer (2016-present)
- Former Administrative Director, Johns Hopkins Breast Center (1997-2018)
- Former Director, Johns Hopkins Cancer Survivorship Programs (2011-2018)
- Professor of Surgery, Johns Hopkins University School of Medicine (2016-present)
- Co-Developer and medical advisory of Work Stride: Johns Hopkins Managing Cancer at Work Program (2012-present)
- Co-founder, the Academy of Oncology Nurse & Patient Navigators (AONN+) (2009- present)
- Co-founder, the Association of Chronic & Complex care Nurse Navigators (ACCCNN) 2021-present
- Former Program Director of AONN+ (2009-2019)
- Editor-in-chief of the Journal of Oncology Navigation and Survivorship (2012-present)
- Author of 20 books and > 350 articles on various cancer topics
- National and international public speaker (1997- present)
A two-time breast cancer survivor, originally diagnosed in her 30s, Lillie has worked tirelessly to improve the care of breast cancer patients around the world. She has worked at Johns Hopkins since 1983. Lillie takes great pride in the Academy of Oncology Nurse & Patient Navigators (AONN+) which has more than 9,000 members. She has served as a consultant for breast cancer for national ABC News and Good Morning America, and has been also consulted regularly by the Today Show and CNN. Lillie serves on 28 medical advisory boards currently.
In 2008, The President of The Johns Hopkins University and their Board of Trustees appointed her to a Distinguished Service Faculty Chair. This is the first and only time in the history of the institution that a hospital nurse has been appointed to a distinguished service designation. She continued to climb the academic ladder and in 2016 was promoted to full professor and is the only nurse at Johns Hopkins to have a primary faculty appointment in the School of Medicine and the only nurse in the country to have reached the highest academic faculty ranking and be appointed to a faculty chair as a University Distinguished Service Professor of Breast Cancer at Johns Hopkins University School of Medicine
In 2009 she co-founded the Academy of Oncology Nurse & Patient Navigators, a national professional organization for those working in the navigation space with oncology patients.
In 2012, she and a colleague created an employee benefit called Work Stride- Managing Cancer at Work. Though originally developed for Johns Hopkins employees, its success resulted in it being offered nationally to other businesses and corporations across the country. She continues her work as a medical advisor within Johns Hopkins Healthcare Solutions to enhance the program and continue to support its growth.
In 2021/2022, she co-founded the Association of Chronic & Complex care Nurse Navigators, a national professional organization for those working in the navigation space with chronic illness and complex care patients.
She has authored 30 books and more than 350 articles on breast cancer, oncology navigation, survivorship, patient advocacy, communicating bad news, end of life, and most recently, chronic illness and complex care.
She has received 62 awards — 54 national awards, 7 state awards, and 1 international award including being inducted into the Maryland Women Hall of Fame, Women in Business Healthcare Trailblazer Award, Johnson & Johnson's Most Amazing Nurse in America award, National Komen for the Cure's Professor of Survivorship award, and several national life time achievement awards. Her research area of focus is preservation of quality of life for patients with metastatic breast cancer.
Currently, a documentary is being made about her life and her life’s work. Filming will be completed in 2022. She tells people she never forgets where she came from — she will always be "a farmer’s daughter."
Lillie Shockney is on the speakers bureau for Pfizer Oncology.
Recent Contributions to PracticeUpdate:
- Real-World Treatment Patterns and Survival Outcomes in Patients With De Novo HER2+ Metastatic Breast Cancer Prior to and After 2013
- Patterns and Outcomes of CNS Metastases in Patients With Breast Cancer With Germline BRCA Pathogenic Variants vs Non-Carriers
- Impact of Allosteric PI3Kα Inhibition on On-Target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations
- Incidence, Multidisciplinary Management, and Prognostic Implication of Ribociclib-Induced Cutaneous Adverse Events in Patients With HR+/HER2− Metastatic Breast Cancer
- Prognostic Value and Distribution Pattern of Tumor-Infiltrating Lymphocytes and Their Subsets in Distant Metastases of Advanced Breast Cancer
- Prevalence of Sexual Dysfunction in Patients With De Novo Metastatic Breast Cancer
- Correlation of ctDNA Variant Allele Frequency With Tumor Disease Burden and Outcomes in Patients With Advanced Breast Cancer
- Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin Induction for Untreated Brain Metastases From Breast Cancer
- Safety and Efficacy of Lasofoxifene Plus Abemaciclib for Treating Women With ESR1-Mutated, ER+/HER2− MBC After Disease Progression on Prior Therapies
- Safety and Efficacy of Lasofoxifene vs Fulvestrant for Treating Women With ESR1-Mutated, ER+/HER2− MBC